Emotion and Symptom-Focused Engagement (EASE) for parents of children with cancer
Official title: Emotion and Symptom-Focused Engagement (EASE) for Caregivers: A Phase III Randomized Controlled Trial of an Intervention Targeting Traumatic Stress in Parents of Children With Cancer
Run by University Health Network, Toronto · NCT06367556 · Data updated 2026-11-12
This trial will test whether adding the EASE psychotherapy to usual care helps parents of children newly diagnosed or relapsed with cancer have fewer traumatic stress symptoms over six months.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 306 (estimated) |
| Sponsor | University Health Network, Toronto Academic / other |
| Locations | 2 sites (Toronto, Ontario and 1 other locations) |
| Status | Recruiting |
| Started | February 14, 2025 |
| Main results expected | October 1, 2027 |
| Study ends | October 1, 2028 |
| Registry record updated | December 17, 2025 |
| Trial ID | NCT06367556 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are English-speaking primary family caregivers aged 18 or older of a child under 18 who was diagnosed or relapsed with a life-threatening cancer within the past six months and is receiving active cancer therapy.
✕Probably not a fit
Caregivers with major cognitive or communication impairments, active suicidal intent, those already in formal psychotherapy, or whose child is not expected to survive the study period are unlikely to be eligible or to benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This Phase III randomized controlled trial compares EASE plus usual care to usual care alone in primary caregivers of children under 18 who have been newly diagnosed or relapsed with life-threatening cancer within the prior six months. Participants complete questionnaires at enrolment and at 4, 8, and 12 weeks and six months, with the primary outcome defined as traumatic stress symptom severity summarized by area under the curve over six months. The trial excludes caregivers with significant cognitive or communication impairment, active suicidal intent, current formal psychotherapy, or whose child is not expected to survive the study period. Optional qualitative interviews will capture caregiver experiences with the intervention.
Why it matters
Potential benefit: If successful, EASE could reduce traumatic stress symptoms in parents and improve their coping and day-to-day functioning while caring for a child with cancer.
How similar studies have gone: Related emotion-focused and symptom-targeted psychotherapies for caregivers have shown some positive results in prior studies, but EASE is a novel, tailored intervention being tested in a definitive Phase III trial.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Self-identified primary family caregiver/guardian (i.e., parent assuming the majority of care activities) of a child: i) \<18yo; ii) diagnosed with a new or relapsed life-threatening cancer within the preceding six months (disease-type eligibility per the Pediatric Oncology Group of Ontario Networked Information System); and iii) receiving active cancer therapy; * Age ≥18 years; and, * Able to complete outcome measures and engage in EASE in English, which need not be their first language. Exclusion Criteria: * Impairment in cognitive functioning or communication that would preclude participation in EASE sessions or outcome measure completion, as determined by the research team; * Receiving formal ongoing psychotherapy at the time of recruitment; * Active suicidal intention, based on an item in the Distress Assessment and Response Tool (DART) that has been widely used in suicidal intention screening in cancer; or, * Child not expected to survive past the duration of trial, as determined by the child's medical team.
Where it's running
-
The Hospital for Sick Children
Toronto, Ontario, Canada Recruiting -
Princess Margaret Cancer Centre - University Health Network
Toronto, Ontario, Canada Active not recruiting
Study contacts
- Study coordinator: Dr. Lindsay Jibb, RN, PhD
- Email: lindsay.jibb@sickkids.ca
- Phone: 416-813-7654
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
FaceSay: a computer program to help kids recognize facial expressions and improve social interactions
A computer-based FaceSay program is tested to see if it helps survivors of pediatric brain tumors who have social difficulties see facial expressions better and relate more comfortably with peers.
-
Lived Experience Narratives in Dementia
This project tests a digital Online LEND Intervention that shares dementia patients’ and caregivers’ lived experiences to see if it helps wellbeing and connection.
-
Online FBT-DBT for Caregivers of Teens with Anorexia Nervosa
This online program tests a combination of family-based and DBT skills to help caregivers of teens with anorexia nervosa manage stress and improve family support.
-
Access to Innovative Cancer Treatments for Children and Young People in Belgium
This observational study collects safety and effectiveness data on off‑label and compassionate cancer medicines used in kids and young adults up to age 25 in Belgium.
-
Support for caregivers of people with heart disease to reduce stress
This study tests whether the Confident Caregiver program can help family caregivers of people with cardiovascular disease feel less burdened and stressed, with sessions delivered virtually.
-
Nurse-led support for caregivers of older adults with advanced lung cancer
This study tests a nurse-led care and resource system to support older adults with advanced lung cancer and their family caregivers.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.